{ "company_number": "06268419", "name": "Sterling Pharmaceuticals Limited", "url": "/company/06268419", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2007-06-04", "dissolved_on": null, "sic_codes": [ { "code": "21200", "description": "Manufacture of pharmaceutical preparations", "section": "C", "section_name": "Manufacturing", "url": "/sic/21200" } ], "registered_address": { "id": 1247161, "url": "/address/1247161", "line1": "385 MOSELEY RD", "line2": "MOSELEY", "post_town": "BIRMINGHAM", "county": "WEST MIDLANDS", "country": "UNITED KINGDOM", "postcode": "B12 9DD" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06268419", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-03-27", "last_made_up": "2025-06-30", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/06268419/accounts/2025-06-30", "pdf_url": "/company/06268419/accounts/2025-06-30.pdf", "made_up_date": "2025-06-30", "period_start": "2024-07-01", "period_end": "2025-06-30", "entity_name": "Sterling Pharmaceuticals Limited", "dormant": false, "average_employees": "49.00", "tangible_fixed_assets": "1675794.00", "debtors": "1261858.00", "cash_bank_in_hand": "1197583.00", "current_assets": "2605522.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "141828.00", "total_assets_less_current_liabilities": "1817622.00", "net_assets_liabilities": "1336017.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "1048766.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2026.zip" }, { "url": "/company/06268419/accounts/2024-06-30", "pdf_url": "/company/06268419/accounts/2024-06-30.pdf", "made_up_date": "2024-06-30", "period_start": "2023-07-01", "period_end": "2024-06-30", "entity_name": "Sterling Pharmaceuticals Limited", "dormant": false, "average_employees": "50.00", "tangible_fixed_assets": "1733555.00", "debtors": "1151516.00", "cash_bank_in_hand": "814445.00", "current_assets": "2128311.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-138579.00", "total_assets_less_current_liabilities": "1594976.00", "net_assets_liabilities": "1187251.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "704338.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2025.zip" }, { "url": "/company/06268419/accounts/2023-06-30", "pdf_url": "/company/06268419/accounts/2023-06-30.pdf", "made_up_date": "2023-06-30", "period_start": "2022-07-01", "period_end": "2023-06-30", "entity_name": "Sterling Pharmaceuticals Limited", "dormant": false, "average_employees": "51.00", "tangible_fixed_assets": "1800025.00", "debtors": "1463006.00", "cash_bank_in_hand": "141775.00", "current_assets": "1920568.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-458032.00", "total_assets_less_current_liabilities": "1341993.00", "net_assets_liabilities": "1032913.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "664336.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2024.zip" }, { "url": "/company/06268419/accounts/2022-06-30", "pdf_url": "/company/06268419/accounts/2022-06-30.pdf", "made_up_date": "2022-06-30", "period_start": "2021-07-01", "period_end": "2022-06-30", "entity_name": "Sterling Pharmaceuticals Limited", "dormant": false, "average_employees": "48.00", "tangible_fixed_assets": "1812524.00", "debtors": "1585250.00", "cash_bank_in_hand": "326843.00", "current_assets": "2443652.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-305205.00", "total_assets_less_current_liabilities": "1507319.00", "net_assets_liabilities": "918577.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "1009235.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2023.zip" }, { "url": "/company/06268419/accounts/2021-06-30", "pdf_url": "/company/06268419/accounts/2021-06-30.pdf", "made_up_date": "2021-06-30", "period_start": "2020-07-01", "period_end": "2021-06-30", "entity_name": "Sterling Pharmaceuticals Limited", "dormant": false, "average_employees": "49.00", "tangible_fixed_assets": "1627218.00", "debtors": "1299538.00", "cash_bank_in_hand": "457439.00", "current_assets": "2333854.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-764484.00", "total_assets_less_current_liabilities": "862734.00", "net_assets_liabilities": "209342.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "1113859.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2022.zip" }, { "url": "/company/06268419/accounts/2020-06-30", "pdf_url": "/company/06268419/accounts/2020-06-30.pdf", "made_up_date": "2020-06-30", "period_start": "2019-07-01", "period_end": "2020-06-30", "entity_name": "Sterling Pharmaceuticals Limited", "dormant": false, "average_employees": "44.00", "tangible_fixed_assets": "1595909.00", "debtors": "1718063.00", "cash_bank_in_hand": "139513.00", "current_assets": "2192620.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-937506.00", "total_assets_less_current_liabilities": "658403.00", "net_assets_liabilities": "395483.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "928971.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2021.zip" }, { "url": "/company/06268419/accounts/2019-06-30", "pdf_url": "/company/06268419/accounts/2019-06-30.pdf", "made_up_date": "2019-06-30", "period_start": "2018-07-01", "period_end": "2019-06-30", "entity_name": "Sterling Pharmaceuticals Limited", "dormant": false, "average_employees": "44.00", "tangible_fixed_assets": "1132098.00", "debtors": "1654337.00", "cash_bank_in_hand": "50803.00", "current_assets": "2012761.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-649057.00", "total_assets_less_current_liabilities": "483041.00", "net_assets_liabilities": "316512.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "302888.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2020.zip" }, { "url": "/company/06268419/accounts/2018-06-30", "pdf_url": "/company/06268419/accounts/2018-06-30.pdf", "made_up_date": "2018-06-30", "period_start": "2017-07-01", "period_end": "2018-06-30", "entity_name": "Sterling Pharmaceuticals Limited", "dormant": false, "average_employees": "44.00", "tangible_fixed_assets": "916953.00", "debtors": "1561164.00", "cash_bank_in_hand": "47543.00", "current_assets": "1756451.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-653329.00", "total_assets_less_current_liabilities": "263624.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "455906.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2019.zip" }, { "url": "/company/06268419/accounts/2017-06-30", "pdf_url": "/company/06268419/accounts/2017-06-30.pdf", "made_up_date": "2017-06-30", "period_start": "2016-07-01", "period_end": "2017-06-30", "entity_name": "Sterling Pharmaceuticals Limited", "dormant": false, "average_employees": "44.00", "tangible_fixed_assets": "636098.00", "debtors": "1085104.00", "cash_bank_in_hand": "62716.00", "current_assets": "1264149.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-478380.00", "total_assets_less_current_liabilities": "157718.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100000.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "558792.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2018.zip" }, { "url": "/company/06268419/accounts/2016-06-30", "pdf_url": "/company/06268419/accounts/2016-06-30.pdf", "made_up_date": "2016-06-30", "period_start": "2016-06-30", "period_end": "2016-06-30", "entity_name": "Sterling Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "865750.00", "debtors": "1121446.00", "cash_bank_in_hand": "549800.00", "current_assets": "1777974.00", "creditors_due_within_one_year": "644798.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1133176.00", "total_assets_less_current_liabilities": "1998926.00", "net_assets_liabilities": null, "called_up_share_capital": "100000.00", "profit_loss_account_reserve": "1898926.00", "shareholder_funds": "1998926.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2016.zip" }, { "url": "/company/06268419/accounts/2015-06-30", "pdf_url": "/company/06268419/accounts/2015-06-30.pdf", "made_up_date": "2015-06-30", "period_start": "2015-06-30", "period_end": "2015-06-30", "entity_name": "Sterling Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "520127.00", "debtors": "857084.00", "cash_bank_in_hand": "895782.00", "current_assets": "1783817.00", "creditors_due_within_one_year": "750338.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1033479.00", "total_assets_less_current_liabilities": "1553606.00", "net_assets_liabilities": null, "called_up_share_capital": "100000.00", "profit_loss_account_reserve": "1453606.00", "shareholder_funds": "1553606.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2016.zip" }, { "url": "/company/06268419/accounts/2014-06-30", "pdf_url": "/company/06268419/accounts/2014-06-30.pdf", "made_up_date": "2014-06-30", "period_start": "2014-06-30", "period_end": "2014-06-30", "entity_name": "Sterling Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "454565.00", "debtors": "1071892.00", "cash_bank_in_hand": "419799.00", "current_assets": "1626033.00", "creditors_due_within_one_year": "766259.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "859774.00", "total_assets_less_current_liabilities": "1314339.00", "net_assets_liabilities": null, "called_up_share_capital": "100000.00", "profit_loss_account_reserve": "1214339.00", "shareholder_funds": "1314339.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2015.zip" }, { "url": "/company/06268419/accounts/2013-06-30", "pdf_url": "/company/06268419/accounts/2013-06-30.pdf", "made_up_date": "2013-06-30", "period_start": "2013-06-30", "period_end": "2013-06-30", "entity_name": "Sterling Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "422846.00", "debtors": "1021231.00", "cash_bank_in_hand": "440747.00", "current_assets": "1485270.00", "creditors_due_within_one_year": "734297.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "750973.00", "total_assets_less_current_liabilities": "1173819.00", "net_assets_liabilities": null, "called_up_share_capital": "100000.00", "profit_loss_account_reserve": "1073819.00", "shareholder_funds": "1173819.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2014.zip" }, { "url": "/company/06268419/accounts/2012-06-28", "pdf_url": "/company/06268419/accounts/2012-06-28.pdf", "made_up_date": "2012-06-28", "period_start": "2012-06-28", "period_end": "2012-06-28", "entity_name": "Sterling Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "401648.00", "debtors": "1021267.00", "cash_bank_in_hand": "196381.00", "current_assets": "1240076.00", "creditors_due_within_one_year": "745785.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "494291.00", "total_assets_less_current_liabilities": "895939.00", "net_assets_liabilities": "895939.00", "called_up_share_capital": "100000.00", "profit_loss_account_reserve": "795939.00", "shareholder_funds": "895939.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2013.zip" }, { "url": "/company/06268419/accounts/2011-06-30", "pdf_url": "/company/06268419/accounts/2011-06-30.pdf", "made_up_date": "2011-06-30", "period_start": "2011-06-30", "period_end": "2011-06-30", "entity_name": "Sterling Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "372697.00", "debtors": "765584.00", "cash_bank_in_hand": "189816.00", "current_assets": "973506.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "166367.00", "total_assets_less_current_liabilities": "539064.00", "net_assets_liabilities": "539064.00", "called_up_share_capital": "100000.00", "profit_loss_account_reserve": "439064.00", "shareholder_funds": "539064.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2012.zip" }, { "url": "/company/06268419/accounts/2010-06-30", "pdf_url": "/company/06268419/accounts/2010-06-30.pdf", "made_up_date": "2010-06-30", "period_start": "2010-06-30", "period_end": "2010-06-30", "entity_name": "Sterling Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "397560.00", "debtors": "570643.00", "cash_bank_in_hand": "79694.00", "current_assets": "666267.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-79348.00", "total_assets_less_current_liabilities": "318212.00", "net_assets_liabilities": "318212.00", "called_up_share_capital": "100000.00", "profit_loss_account_reserve": "218212.00", "shareholder_funds": "318212.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2011.zip" } ], "pdf_only_filings": [ { "made_up_date": "2009-06-30", "filing_date": "2009-09-09", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": true, "pdf_url": "/company/06268419/accounts/2009-06-30.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06268419/filing-history/MjA0MTAwMzIzOGFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2008-06-30", "filing_date": "2009-06-24", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": true, "pdf_url": "/company/06268419/accounts/2008-06-30.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06268419/filing-history/MjAzNTc1NjI5OWFkaXF6a2N4/document?format=pdf&download=0" } ], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/06268419/filing-history" }, "confirmation_statement": { "next_due": "2027-02-01", "last_made_up": "2026-01-18" }, "officers": [], "psc": [ { "name": "Dr Qamar Nawaz", "kind": "individual-person-with-significant-control", "person_url": "/person/4046759", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent", "right-to-appoint-and-remove-directors" ], "notified_on": "2016-04-06", "ceased_on": "2016-07-14", "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" }, { "name": "Ubh Holdings Limited", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/10278605", "natures_of_control": [ "ownership-of-shares-75-to-100-percent", "voting-rights-75-to-100-percent", "right-to-appoint-and-remove-directors" ], "notified_on": "2016-07-14", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-09-01", "retrieved_at": "2026-09-20T03:23:56.377763+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }